| Identification | Back Directory | [Name]
2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[(1R)-6-fluoro-1,2,3,4-tetrahydro-1-methylpyrido[1,2-a]benzimidazol-8-yl]- | [CAS]
2397678-18-9 | [Synonyms]
Tibremciclib
2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[(1R)-6-fluoro-1,2,3,4-tetrahydro-1-methylpyrido[1,2-a]benzimidazol-8-yl]- | [Molecular Formula]
C28H32F2N8 | [MOL File]
2397678-18-9.mol | [Molecular Weight]
518.6 |
| Hazard Information | Back Directory | [Uses]
Tibremciclib is a CDK4 inhibitor with antineoplastic activity[1]. | [References]
[1] Wang Yiqian, et al. Crystal form of compound useful as CDK4/6 inhibitors for the treatment of cancer. World Intellectual Property Organization, WO2019242719 A1. 2019-12-26. |
|
|